Trial Profile
Open-label, Randomized, Single Dose Crossover Study to Evaluate the Pharmacokinetics and Safety of Singulair (10 mg) and Xyzal (5 mg) in Free Combination and Fixed-dose Combination as HCP1102 in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Levocetirizine/montelukast (Primary) ; Levocetirizine; Montelukast
- Indications Asthma; Rhinitis
- Focus Pharmacokinetics
- 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Aug 2012 New trial record